125 related articles for article (PubMed ID: 7890911)
1. The immunogenetic basis for anti-neutrophil cytoplasmic antibody production in primary sclerosing cholangitis and ulcerative colitis.
Mehal WZ; Lo SK; Chapman RW; Fleming KA
J Hepatol; 1994 Nov; 21(5):910-1. PubMed ID: 7890911
[No Abstract] [Full Text] [Related]
2. The enigma of anti-neutrophil antibodies in ulcerative colitis primary sclerosing cholangitis: important genetic marker or epiphenomenon?
Chapman RW
Hepatology; 1995 May; 21(5):1473-4. PubMed ID: 7737656
[No Abstract] [Full Text] [Related]
3. Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis.
Bansi DS; Lo S; Chapman RW; Fleming KA
Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):111-6. PubMed ID: 8723413
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.
Duerr RH; Targan SR; Landers CJ; LaRusso NF; Lindsay KL; Wiesner RH; Shanahan F
Gastroenterology; 1991 May; 100(5 Pt 1):1385-91. PubMed ID: 2013383
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.
Seibold F; Slametschka D; Gregor M; Weber P
Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629
[TBL] [Abstract][Full Text] [Related]
6. [Antibodies to neutrophilic granulocytes (p-ANCA): a further indication for a common origin of ulcerative colitis and primary sclerosing cholangitis?].
Jahn HU; Zeitz M
Z Gastroenterol; 1992 Jun; 30(6):441-2. PubMed ID: 1636280
[No Abstract] [Full Text] [Related]
7. Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis.
Haagsma EB; Mulder AH; Gouw AS; Horst G; Meerman L; Slooff MJ; Kallenberg CG
J Hepatol; 1993 Aug; 19(1):8-14. PubMed ID: 8301047
[TBL] [Abstract][Full Text] [Related]
8. HLA antigens in ulcerative colitis and primary sclerosing cholangitis.
Leidenius MH; Koskimies SA; Kellokumpu IH; Höckerstedt KA
APMIS; 1995; 103(7-8):519-24. PubMed ID: 7576567
[TBL] [Abstract][Full Text] [Related]
9. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases.
Zauli D; Baffoni L; Cassani F; Fusconi M; Lenzi M; Ballardini G; Luigi M; Bianchi FB; Schrumpf E
Gastroenterology; 1992 Mar; 102(3):1088-90. PubMed ID: 1537507
[No Abstract] [Full Text] [Related]
10. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH
Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases.
Tervaert JW; Mulder AH; Horst G; Haagsma EB; Kleibeuker JH; Kallenberg CG
Gastroenterology; 1992 Mar; 102(3):1090-1. PubMed ID: 1537508
[No Abstract] [Full Text] [Related]
12. Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique.
Lo SK; Fleming KA; Chapman RW
Gut; 1992 Oct; 33(10):1370-5. PubMed ID: 1446862
[TBL] [Abstract][Full Text] [Related]
13. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.
Bansi DS; Fleming KA; Chapman RW
Gut; 1996 Mar; 38(3):384-9. PubMed ID: 8675091
[TBL] [Abstract][Full Text] [Related]
14. Association of primary sclerosing cholangitis, ulcerative colitis and coeliac disease in female siblings.
Habior A; Rawa T; Orłowska J; Sankowska M; Lewartowska A; Tilszer A; Pawlak J; Krawczyk M; Butruk E
Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):787-91. PubMed ID: 12169991
[TBL] [Abstract][Full Text] [Related]
15. Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.
Chapman RW; Cottone M; Selby WS; Shepherd HA; Sherlock S; Jewell DP
Gut; 1986 Jan; 27(1):86-91. PubMed ID: 3485067
[TBL] [Abstract][Full Text] [Related]
16. Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.
Peen E; Almer S; Bodemar G; Rydén BO; Sjölin C; Tejle K; Skogh T
Gut; 1993 Jan; 34(1):56-62. PubMed ID: 8432453
[TBL] [Abstract][Full Text] [Related]
17. Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis.
Pokorny CS; Norton ID; McCaughan GW; Selby WS
J Gastroenterol Hepatol; 1994; 9(1):40-4. PubMed ID: 8155865
[TBL] [Abstract][Full Text] [Related]
18. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.
Vidrich A; Lee J; James E; Cobb L; Targan S
J Clin Immunol; 1995 Nov; 15(6):293-9. PubMed ID: 8576315
[TBL] [Abstract][Full Text] [Related]
19. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
20. HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis.
Zetterquist H; Broomé U; Einarsson K; Olerup O
Gut; 1992 Jul; 33(7):942-6. PubMed ID: 1644334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
